Work for Zealand Pharma?
Brief our analysts.
Get in front of tech buyers.
You May Also Like
Metronome Therapeutics is developing oncology drugs
Developer of novel variants of peptide drugs.
Xytis is engaged in the development of central nervous systems drugs.
OyaGen is a biotechnology company discovering, developing, and commercializing pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. The company will pursue several assays in high throughput screening strategies for drug development. OyaGen seeks to bring to market the anti-HIV drugs targeting Vif and APOBEC3G that solve the problems of viral resistance, a major shortcoming of all current therapies. In the long run, the Company will draw on its core expertise in Editing Enzyme technologies to develop therapies for other disease states.
KeyBay Pharma is dedicated to the discovery, development and commercialization of antibiotics.
Endotis Pharma is A specialty discovery and development company developing small glycol drugs for thrombosis and oncology
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.